Chemotherapy for brain tumors in adult patients;Chemotherapie von hirntumoren bei erwachsenen

Nervenarzt

Volumn 79, Issue 2, 2008, Pages 231-241

  Weller, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Brain tumor; Chemotherapy; Chromosomal arm 1p and 19q; Neuro oncology; O6 methylguanin DNA methyltransferase

Indexed keywords

BEVACIZUMAB; CARMUSTINE; CILENGITIDE; CISPLATIN; CYTARABINE; ENZASTAURIN; ERLOTINIB; ETOPOSIDE; GEFITINIB; IMATINIB; IRINOTECAN; LOMUSTINE; METHOTREXATE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; PROCARBAZINE; RAPAMYCIN; RETINOID; TEMOZOLOMIDE; TEMSIROLIMUS; TENIPOSIDE; THIOTEPA; TOPOTECAN; VATALANIB; VINCRISTINE; VORINOSTAT;

ADJUVANT THERAPY; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ARM; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; EMBRYONAL CARCINOMA; EPENDYMOMA; EPIGENETICS; GERM CELL TUMOR; GLIOBLASTOMA; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; LYMPHOMA; MEDULLOBLASTOMA; MENINGIOMA; PERIPHERAL NERVE TUMOR; PINEAL BODY TUMOR; PINEAL PARENCHYMA TUMOR; PRIMARY CEREBRAL LYMPHOMA; PROGNOSIS; REVIEW; TERATOMA;

EID: 38949108960     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2372-3     Document Type: Review

References (20)

1. Bent MJ van den, Carpentier AF, Brandes AA et al. (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24: 2715-2722
2. Brandes AA, Cavallo G, Reni M et al. (2005) A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 104: 143-148
3. Cairncross G, Berkey B, Shaw E et al. (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24: 2707-2714
4. Chamberlain MC (2006) Neoplastic meningitis. Neurologist 12: 179-187
5. Diener HC, Putzki N, Berlit P (Hrsg) (2005) Leitlinien für Diagnostik und Therapie in der Neurologie. Deutsche Gesellschaft für Neurologie. Thieme, Stuttgart
6. Hegi ME, Diserens AC, Gorlia T et al. (2005) MGMT gene silencing and response to temozolomide in glioblastoma. N Engl J Med 352: 997-1003
7. Herrlinger U, Steinbrecher A, Rieger J et al. (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 252: 291-299
8. Kleihues P, Cavenee WK (2000) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Nervous System. IARC Press, Lyon
9. Lutterbach J, Fauchon F, Schild SE et al. (2002) Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery 51: 44-55
10. Neuro-Oncology Oncology Group (NOA) of the German Cancer Society (2003) Neuro-Oncology Working Group (NOA)-01 trial of radiotherapy plus adjuvant ACNU/VM26 versus ACNU/Ara-C chemotherapy for maligant glioma. J Clin Oncol 21: 3276-3284
11. Peak S, Abrey LE (2006) Chemotherapy and the treatment of brain metastases. Hematol Oncol Clin North Am 20: 1287-1295
12. Pels H, Schlegel U (2006) Primary central nervous system lymphoma. Curr Treat Options Neurol 8: 346-357
13. Schlegel U, Weller M, Westphal M (Hrsg) (2003) Neuro-Onkologie. Thieme, Stuttgart
14. Silvani A, Eoli M, Salmaggi A et al. (2005) Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study. J Neurooncol 71: 271-276
15. Stupp R, Mason WP, Bent MJ van den et al. on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) (2005) Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma. N Engl J Med 352: 987-996
16. Vredenburgh JJ, Desjardins A, Herndon JE 2nd et al. (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13: 1253-1259
17. Weller M (2003) Neuroonkologie. Nervenarzt 74: 1139-1149
18. Westphal M, Ram Z, Riddle V et al. Executive Committee of the Gliadel Study Group (2006) Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148: 269-275
19. Wick A, Felsberg J, Steinbach JP et al. (2007) Efficacy and tolerability of temozolomide in an one week on/one week off regimen in patients with recurrent glioma. J Clin Oncol 25: 3357-3361
20. Wick W, Tonn JC, Weller M (2007) Primäre intrakranielle und spinale Tumoren. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, Stuttgart, S 832-867